Can Cell & Gene Therapy Overcome Challenge to Replace Modern Medicine?
Added: (Mon Dec 17 2018)
Pressbox (Press Release) -
After the approval of the first two CAR –T cell therapies for cancer in the US, the blood cancer treatment has transformed tremendously. Apart from the CAR–T cell therapy, Spark’s Luxturna therapy to fix the genetic mutation that causes blindness can be used soon in Europe. Though this wave of change is driving the treatments which seemed impossible few years ago, it is important to remember that this field is still in its initial stage and certain critical challenges still need to be resolved.
The development of an ideal vector system is the biggest challenge in gene therapy as of now. The ideal vector is able to deliver genes effectively and is easy to administer. It should also be very specific when it comes to target cells. Other challenges include adverse events such as Cytokine storms which poses a danger of putting clinical trials on hold. Along with these challenges, the industry is also facing hurdles like difficulty in procuring funding and global regulatory differences.
In an initiative to explore the advancements, innovation and challenges faced in cell and gene therapies, UMS Conferences announces Excellence - The Cell & Gene Therapy Conclave, scheduled on 21 -22 March 2019 in London, UK.
150+ decision makers and active innovators from a diverse range of pharma and biotech companies as well as academia and research institutions will be joining the conclave to discuss critical topics such as Stem Cell Bioprocessing, Stem Cell Manufacturing, 3D Cell Culture and many more.
Speakers for the conclave include Professor Dragan Primorac, Former Minister of Science, Education and Sports of The Republic of Croatia Global Ambassador Penn State University, President of the Board of Trustees - St. Catherine Hospital, Croatia/Germany; Dr. Yuan Zhao, Principal Scientist Lead Gene Therapy Section, NIBSC-Medicines and Healthcare Regulatory Authority UK; Uta Griesenbach, President, British Society for Gene and Cell Therapy; Hanna Leinonen, Senior Scientist, Kuopio Centre for Gene and Cell Therapy; Sarah Snykers, QC Manager, Celyad S.A.; Yaohe Wang, Professor of Cancer Cell and Gene Therapy, Barts Cancer Institute- Queen Mary University of London; Dr. Vasiliki (E) Kalodimou, Director at Flow Cytometry-Research & Regenerative Medicine Department, IASO Maternity & Research Hospital; Prof. Shimon Slavin, Scientific & Medical Director-Biotherapy International, The Center for Innovative Cancer Immunotherapy & Regenerative Medicine; Anna Perdrix Rosell, Co-Founder, Sixfold Bioscience; Lior Raviv, Vice President-Development, Pluristem Therapeutics; Dr. John Maher, Clinical Senior Lecturer in Immunology Honorary Consultant Immunologist, King’s College Hospital NH, Foundation Trust; Stephen Hyde, Founding Principal Investigator, The UK CF Gene Therapy, Consortium, Associate Professor, Molecular Therapy; Dr. Suwan N. Jayasinghe; Head of BioPhysics Group, Professor of Bioengineering, University College London; John D Isaacs, Professor of Clinical Rheumatology, Newcastle University; Benjamin Draper, CAR T-Cell Immunotherapy Group, King’s College London; Dr. Narendra Chirmule, Head - Research & Development, Biocon among others
About UMS Conferences:
Founded in 2015, UMS Conferences is a wholly owned subsidiary of United Media Services LLC, a leading media and communications company.
UMS Conferences has an extensive portfolio of industry-leading and stimulating summits, conferences, awards, strategic forums and expos around the world. It is known for building platforms that create value and deliver an unmatched delegate experience. Our events offer premium branding as well as networking opportunities for partners.
As businesses face disruptive challenges, there has never been a greater need for more knowledge and opportunities to collaborate and network. Our carefully curated conferences combine deep editorial insights with award winning event concepts, distilling the onslaught of information into something that can generate profits.
With flagship events like New Age Banking Summit, UAE-India Economic Forum, Global Blockchain Congress, Healthcare Innovation Summit, IoT Integration Summit, Finsec and CDO Conclave, UMS Conferences attracts a high calibre of delegates, speakers and partners, who value the knowledge we offer. Aligning with these events is a powerful way to engage with a high-profile audience and reinforce expertise and credibility.
Media Contact:
Apeksha Verma
apeksha@umsconferences.com
W: http://cgt.umsconferences.com
Office # 802, Tower ONE, World Trade Centre,
Pune 411014, Maharashtra, India.